ISDA

Deposition Date 2009-10-26

Release Date 2010-11-10

Last Version Date 2024-02-21

Entry Detail

PDB ID:

3KEJ

Keywords:

HYDROLASE/HYDROLASE INHIBITOR

Title:

Crystal Structure of Human MMP-13 complexed with a (pyridin-4-yl)-2H-tetrazole compound

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Escherichia coli

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.30 Å

R-Value Free:

0.23

R-Value Work:

0.18

R-Value Observed:

0.18

Space Group:

P 21 21 2

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Collagenase 3
Gene (Uniprot):MMP13
Chain IDs:A, B
Chain Length:167
Number of Molecules:2
Biological Source:Homo sapiens

UniProt ID:P45452 Pfam ID:PF00413 EC:3.4.24.17

Primary Citation

Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.

Schnute, M.E, O'Brien, P.M, Nahra, J, Morris, M, Howard Roark, W, Hanau, C.E, Ruminski, P.G, Scholten, J.A, Fletcher, T.R, Hamper, B.C, Carroll, J.N, Patt, W.C, Shieh, H.S, Collins, B, Pavlovsky, A.G, Palmquist, K.E, Aston, K.W, Hitchcock, J, Rogers, M.D, McDonald, J, Johnson, A.R, Munie, G.E, Wittwer, A.J, Man, C.F, Settle, S.L, Nemirovskiy, O, Vickery, L.E, Agawal, A, Dyer, R.D, Sunyer, T.Show

Bioorg.Med.Chem.Lett. 20 576 580 (2010)

PMID: 20005097 DOI: 10.1016/j.bmcl.2009.11.081

Abstact

Potent, highly selective and orally-bioavailable MMP-13 inhibitors have been identified based upon a (pyridin-4-yl)-2H-tetrazole scaffold. Co-crystal structure analysis revealed that the inhibitors bind at the S(1)(') active site pocket and are not ligands for the catalytic zinc atom. Compound 29b demonstrated reduction of cartilage degradation biomarker (TIINE) levels associated with cartilage protection in a preclinical rat osteoarthritis model.

Legend

Protein

Chemical

Disease

Primary Citation of related structures